Today's Top 20 Healthcare News Articles
-
5 reasons Ozempic's price could drop
As the demand for GLP-1 drugs grows, there are several factors emerging that could result in its price decreasing. -
Cardinal Health to acquire Integrated Oncology Network for $1.1B
Cardinal Health plans to acquire Integrated Oncology Network for $1.115 billion in cash, expanding its business into oncology services, according to a Sept. 20 news release from the company. -
Chemotherapy patients under Medicare Advantage use fewer resources: Study
Medicare Advantage beneficiaries used what amounted to $8,718 less in resources than traditional Medicare beneficiaries within six months of beginning chemotherapy treatment, according to a study published Sept. 20 in JAMA Network Open.
-
FTC sues nation's 3 largest PBMs: 10 notes
After weeks of internal disagreements at the Federal Trade Commission about pharmacy benefit managers, the agency said Sept. 20 that it is suing CVS Caremark, Optum Rx and Express Scripts over allegedly inflating insulin prices. -
HCA Utah hospital names COO
Rustin Beck has been named COO of Lakeview Hospital in Bountiful, Utah, according to a Sept. 20 LinkedIn post from the hospital. -
Change Healthcare overhauls systems after cyberattack
UnitedHealth Group subsidiary Change Healthcare had to "start over" with its computer systems following a ransomware attack in February, Cyberscoop reported Sept. 19. -
Drugmakers to discontinue fentanyl 'lollipops': FDA
Drugmakers will discontinue the sales of a controversial class of fentanyl-based painkillers by the end of September, the FDA confirmed Sept. 16.
-
Top-ranked hospitals for coronary bypass, by state
Florida has the most top ranked hospitals for coronary bypass in the U.S., according to the WebMD Choice Awards. -
42 recent hospital, health system executive moves
The following hospital and health system executive moves have been shared with or reported by Becker's this year: -
Bionpharma recalls pneumonia medication
Bionpharma is recalling a batch of pneumonia drug Atovaquone Oral Suspension after it was found to be contaminated with Cohnella bacteria. -
Ohio hospital COO steps down
Bernie Albertini stepped down from his role as administrator and chief operating officer of East Ohio Regional Hospital in Martins Ferry, effective Sept. 16.
-
$25M gift to fund Michigan Medicine breast cancer center
Ann Arbor-based Michigan Medicine will establish the Weiser Family Center for Breast Cancer after receiving a $25 million gift from the Weiser Charitable Foundation. -
Healthcare leads in signing bonus offers
Healthcare tops the list of industries offering signing bonuses, according to Indeed job listings, The Wall Street Journal reported Sept. 19. -
UC Riverside med school to create curriculum on substance use care
Researchers at the University of California Riverside School of Medicine are developing a curriculum to educate future physicians on caring for patients with substance use disorders. -
Kaleida Health chief administrative officer to step down
Michael Hughes, senior vice president and chief administrative officer of Buffalo, N.Y.-based Kaleida Health, will depart the organization at the end of year. -
Erlanger Foundation chief development officer to retire
Julie Taylor, president and chief development officer of Erlanger Health System's philanthropic arm, will retire on Sept. 30, according to a news release from the Chattanooga, Tenn.-based health system. -
Clearing a path for diverse leadership
Creating a diverse nurse workforce and leadership team takes intentionality. -
4 viruses-linked cancers that could become rare
Infections account for an estimated 13% of all cancer cases globally, the American Association for Cancer Research found, but more work is needed to help patients prevent these infections, The New York Times reported Sept. 18. -
Cleveland Clinic trial shows promise in treating bleeding disorder
A phase 2 clinical trial has demonstrated that pomalidomide, used to treat bone marrow cancer, is safe and effective for managing hereditary hemorrhagic telangiectasia, a rare genetic bleeding disorder. The results were published Sept. 18 in the New England Journal of Medicine. -
Ascension's 'size and scale' helps secure 'AA+' rating: Fitch
St. Louis-based Ascension, a 136-hospital system, had its issuer default rating and long-term revenue bond ratings affirmed at "AA+" due to its strong operational profile, key leverage metrics and robust balance sheet, according to a Sept. 20 Fitch Ratings report.
Page 12 of 50